Please use this identifier to cite or link to this item:
|Title:||Nuclear deformation during breast cancer cell transmigration||Authors:||VanDongen, Antonius M. J.
Chin, Lip Ket
Liu, Ai Qin
|Keywords:||DRNTU::Science::Medicine::Biomedical engineering||Issue Date:||2012||Source:||Fu, Y., Chin, L. K., Bourouina, T., Liu, A. Q., & VanDongen, A. M. J. (2012). Nuclear deformation during breast cancer cell transmigration. Lab on a Chip, 12(19), 3774-3778.||Series/Report no.:||Lab on a chip||Abstract:||Metastasis is the main cause of cancer mortality. During this process, cancer cells dislodge from a primary tumor, enter the circulation and form secondary tumors in distal organs. It is poorly understood how these cells manage to cross the tight syncytium of endothelial cells that lines the capillaries. Such capillary transmigration would require a drastic change in cell shape. We have therefore developed a microfluidic platform to study the transmigration of cancer cells. The device consists of an array of microchannels mimicking the confined spaces encountered. A thin glass coverslip bottom allows high resolution imaging of cell dynamics. We show that nuclear deformation is a critical and rate-limiting step for transmigration of highly metastatic human breast cancer cells. Transmigration was significantly reduced following the treatment with a protein methyltransferase inhibitor, suggesting that chromatin condensation might play an important role. Since transmigration is critical for cancer metastasis, this new platform may be useful for developing improved cancer therapies.||URI:||https://hdl.handle.net/10356/98194
|DOI:||10.1039/c2lc40477j||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||EEE Journal Articles|
Updated on Jan 27, 2023
Web of ScienceTM
Updated on Jan 24, 2023
Page view(s) 20651
Updated on Feb 1, 2023
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.